MicroRNA-152 Inhibits Cell Proliferation, Migration, and Invasion in Breast Cancer

Author:

Maimaitiming Adilijiang1,Wusiman Ailijiang2,Aimudula Abulajiang2,Kuerban Xuekelaiti1,Su Pengcheng1

Affiliation:

1. Department of Breast and Thyroid Surgery, People’s Hospital of Xinjiang Uygur Autonomous RegionUrumqiP.R. China

2. Department of Surgery, Hospital of Xinjiang Traditional UyghurUrumqiP.R. China

Abstract

The aim of the present study was to investigate the roles of microRNA-152 (miR-152) in the initiation and progression of breast cancer. The expression level of miR-152 was detected in human breast cancer tissue and a panel of human breast cancer cell lines using qRT-PCR. Results found that miR-152 expression was significantly downregulated in breast cancer tissue samples compared to adjacent noncancerous tissues as well as in breast cancer cell lines. Overexpression of miR-152 significantly suppressed breast cancer cell proliferation, migration, and invasion. Luciferase reporter assay results found that ROCK1 is a direct and functional target gene of miR-152 in breast cancer. In addition, downexpression of ROCK1 could inhibit breast cancer cell proliferation, migration, and invasion. These findings indicate that miR-152 inhibited breast cancer growth and metastasis through negative regulation of ROCK1 expression. These data suggest that miR-152/ROCK1 pathway may be a useful therapeutic target for breast cancer treatment.

Publisher

Cognizant, LLC

Subject

Cancer Research,Oncology,General Medicine

Reference37 articles.

1. Clinicopathologic features of breast cancer patients with type 2 diabetes mellitus in southwest of China;Med Oncol.,2014

2. Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR;Biomark Res.,2015

3. MiR-449a promotes breast cancer progression by targeting CRIP2;Oncotarget,2016

4. Pitfalls in outcome prediction of breast cancer;J Clin Pathol.,2013

5. A new frontier for molecular medicine: Noncoding RNAs;Biochim Biophys Acta,2005

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3